ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Biomedical Panel Report Will Support Cancer Program, Targeted Research

January 16, 1976

NCI Get Go-Ahead For New Cancer Control Projects Totaling $7.4 Million, Funded By Grants, Contracts

October 21, 1977

Abstracts Of “Most Newsworthy” Papers At AACR Meeting

May 27, 1977

Nurse Participation In International Congress Increases

September 19, 1986

Clearinghouse Finds Insecticide, Hair Dye Are Carcinogens

December 1, 1978

FDA Advisors Discuses Establishment of Standards for Showing Equivalence

December 17, 1999